Changeflow GovPing Pharma & Drug Safety Cannabinoid Derivatives, Precursors and Uses - ...
Routine Rule Added Final

Cannabinoid Derivatives, Precursors and Uses - Patent US12600707B2

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO granted patent US12600707B2 to Kare Chemical Technologies Inc. on April 14, 2026, covering new cannabinoid derivatives, precursors, and processes for their preparation. The patent also claims pharmaceutical and analytical uses of these compounds. The patent (10 claims) protects the invention until 2040 based on the September 2020 filing date.

What changed

USPTO issued patent US12600707B2 to Kare Chemical Technologies Inc. for new cannabinoid derivatives, precursors, and processes for their preparation, along with pharmaceutical and analytical uses. The patent contains 10 claims under CPC classification C07D 311/80.

Competitors developing similar cannabinoid derivative products may need to license the patent or design around the claims to avoid infringement. Pharmaceutical companies and manufacturers working in this chemical space should review the granted claims for potential licensing opportunities or validity challenges.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Cannabinoid derivatives, precursors and uses

Grant US12600707B2 Kind: B2 Apr 14, 2026

Assignee

KARE CHEMICAL TECHNOLOGIES INC.

Inventors

Kamaluddin Abdur-Rashid, Wenli Jia, Kareem Abdur-Rashid

Abstract

The present disclosure relates to new cannabinoid derivatives and precursors and processes for their preparation. The disclosure also relates to pharmaceutical and analytical uses of the new cannabinoid derivatives.

CPC Classifications

C07D 311/80

Filing Date

2020-09-03

Application No.

17753616

Claims

10

View original document →

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12600707B2

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent licensing Pharmaceutical R&D Chemical manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!